Trial NCT05554341

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2022-07264
Secondary IDs: EAY191-E4 NCI-2022-07264 U10CA180820

Last trial update was posted on 2024-04-09

MeSH Interventions

Albumin-Bound Paclitaxel Nilotinib Paclitaxel

MeSH Conditions

Neoplasms

Other Conditions

Metastatic Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm

Stopping Reasons

Scheduled Interim Monitoring

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID